Neogenomics Inc (NEO): who owns it and who trades it
As of Nov 16, 2026, NEO insiders reported 5 open-market sales worth $968K and no purchases in the last 12 months, with 67% of the sale value made under pre-set 10b5-1 plans. The largest seller was Greg D Aunan (Chief Accounting Officer), with $321K. 3 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Neogenomics
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Famous investors and Congress mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns NEO
264 funds and institutions reported NEO shares worth $2.1B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 16.0%.
Funds and institutions (13F) about 100%Everyone else 0%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 20.87M | 16.03% | $304M | +5% |
| First Light Asset Management, LLC | 12.28M | 9.43% | $179M | +26% |
| First Trust Advisors LP | 10.11M | 7.77% | $148M | +64% |
| Greenhouse Funds LLLP | 8.57M | 6.58% | $125M | -6% |
| Vanguard Portfolio Management LLC | 8.06M | 6.19% | $118M | +6% |
| Vanguard Capital Management LLC | 5.76M | 4.43% | $84.1M | +2% |
| State Street Corp | 5.36M | 4.12% | $78.3M | +5% |
| Nomura Asset Management International Inc. | 5.04M | 3.87% | $73.5M | +46% |
| Braidwell LP | 4.92M | 3.78% | $71.8M | -12% |
| Schroder Investment Management Group | 4.34M | 3.34% | $61.9M | +22% |
| Geode Capital Management, LLC | 3.43M | 2.63% | $50M | +6% |
| Millennium Management LLC | 3.08M | 2.37% | $44.9M | +39% |
| Loomis Sayles & Co L P | 2.54M | 1.95% | $37M | +30% |
| Driehaus Capital Management LLC | 2.51M | 1.93% | $36.6M | +46% |
| Bank of America Corp | 2.44M | 1.87% | $35.5M | -20% |
| Dimensional Fund Advisors LP | 2.40M | 1.84% | $35M | -10% |
| Arrowstreet Capital, Limited Partnership | 2.39M | 1.84% | $34.9M | – |
| American Capital Management Inc | 2.24M | 1.72% | $32.6M | -1% |
| D. E. Shaw & Co., Inc. | 2.19M | 1.69% | $32M | -47% |
| Samlyn Capital, LLC | 2.13M | 1.64% | $31.1M | -17% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, NEO insiders reported $0 of open-market purchases and $968K of sales. 67% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | Greg D Aunan | Chief Accounting Officer | Sale | 20,000 | $16.07 | $321K | Form 4 |
| Jun 15, 2026 | Lynn A. Tetrault | Director | Sale plan | 5,307 | $11.10 | $58.9K | Form 4 |
| Jun 9, 2026 | Lynn A. Tetrault | Director | Sale plan | 5,307 | $11.29 | $59.9K | Form 4 |
| Jan 20, 2026 | Warren Stone | Pres & Chief Operating O | Sale plan | 22,128 | $12.50 | $277K | Form 4 |
| Nov 25, 2025 | Alicia C Olivo | Vice president | Sale plan | 20,916 | $12.00 | $251K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Greg D Aunan | Chief Accounting Officer | – | $321K | Aug 4, 2026 |
| Warren Stone | Pres & Chief Operating Officer | – | $277K | Jan 20, 2026 |
| Alicia C Olivo | EVP, GC & Business Development | – | $251K | Nov 25, 2025 |
| Lynn A. Tetrault | Director | – | $119K | Jun 15, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
NEO short interest
High short interest. 10.2% of NEO shares are sold short: about 1 share in 10. Over the last 12 reports the number of shares short went up 52%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 13.13M NEO shares were sold short, 10.2% of the shares outstanding, down 7.6% from the report before. At the average daily volume of 1.97M shares, buying them all back would take about 6.7 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 13.13M | 10.15% | -8% | 1.97M | 6.7 |
| Oct 15, 2026 | 14.22M | 11.06% | +0% | 2.36M | 6.0 |
| Sep 30, 2026 | 14.15M | 11.01% | -15% | 2.49M | 5.7 |
| Sep 15, 2026 | 16.71M | 13.01% | +6% | 1.50M | 11.2 |
| Aug 31, 2026 | 15.76M | 12.27% | -1% | 1.75M | 9.0 |
| Aug 14, 2026 | 15.88M | 12.36% | +3% | 1.91M | 8.3 |
| Jul 31, 2026 | 15.42M | 12.00% | +12% | 3.70M | 4.2 |
| Jul 15, 2026 | 13.76M | 10.57% | +18% | 2.29M | 6.0 |
| Jun 30, 2026 | 11.62M | 8.92% | +37% | 5.50M | 2.1 |
| Jun 15, 2026 | 8.45M | 6.49% | -0% | 1.53M | 5.5 |
| May 29, 2026 | 8.49M | 6.52% | -2% | 1.23M | 6.9 |
| May 15, 2026 | 8.62M | 6.62% | -10% | 1.57M | 5.5 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded NEO
Since Nov 17, 2024, 1 member of Congress reported 2 purchases and 0 sales of NEO. The latest was a purchase by Gilbert Ray Cisneros, Jr. on Aug 7, 2026, reported Sep 10, 2026.
Purchases 2Sales 0
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | Sep 10, 2026 | Report |
| May 7, 2025 | Gilbert Ray Cisneros, Jr. (D-CA) | Purchase | $1K–$15K | Self | Jun 6, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Neogenomics company events
Neogenomics filed 15 reports on Form 8-K in the last 12 months, 6 of them about an important change (leadership). The latest was on Oct 28, 2026.
- Oct 28, 2026ResultsReleased financial results. Filing
- Oct 5, 2026LeadershipDeparture of Directors of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Filing
- Aug 11, 2026LeadershipNeoGenomics, Inc. announced that Alicia Olivo, EVP, General Counsel & Business Development, would transition from her role with the Company and cease to serve as General Counsel effective as of September 21, 2026. Filing
- Jul 28, 2026ResultsReleased financial results. Filing
- Jul 22, 2026AnnouncementAmended an earlier report. Which incorrectly referred to the date “June 20, 2026.” The correct date in each instance is July 20, 2026, consistent with the date of the earliest event reported set forth on the cover page of the Original Form 8-K and the date of the press release furnished as Exhibit 99.1 to the Original Form… Filing
- Jul 20, 2026AnnouncementAs previously disclosed, the Company voluntarily conducted an internal investigation that focused on the compliance of certain consulting and service agreements with federal healthcare laws and regulations, including those relating to fraud, waste and abuse. Filing
- Jun 25, 2026LeadershipThe Board of Directors of NeoGenomics, Inc. increased the size of the Board from nine to ten directors and appointed Carolyn S. Starrett as a director to fill the newly created vacancy, effective immediately. Filing
- Jun 22, 2026AgreementEntry Into or Amendment of a Material Definitive Agreement. Filing
- Jun 17, 2026AnnouncementNeoGenomics, Inc. issued a press release relating to the pricing of its offering of convertible senior notes due 2032 to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. Filing
- Jun 15, 2026AnnouncementNeoGenomics, Inc. issued a press release relating to the commencement of its proposed offering of convertible senior notes due 2032 to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. Filing
- May 22, 2026LeadershipNeoGenomics, Inc. held an annual meeting of its stockholders. Filing
- Apr 28, 2026ResultsReleased financial results. Filing
- Feb 17, 2026ResultsReleased financial results. Filing
- Jan 12, 2026LeadershipDeparture of Directors of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Filing
- Dec 30, 2025LeadershipThe Board of Directors of NeoGenomics, Inc. accepted the resignation of Dr. Alison L. Hannah as a director of the Company effective December 31, 2025. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Neogenomics financials
Famous investors that hold NEO
3 of the 50 well-known investors we track reported holding NEO in their latest 13F filing. The largest position is Israel Englander's, worth $42M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Israel Englander · Millennium Management | Q3 2026 | 2.29M | $42M | 0.0% | -26% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 317,390 | $5.8M | 0.0% | New |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 32,362 | $594K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named NEO in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | First Light Asset Management, LLC | 13G/A | 6.5% |
| Nov 16, 2026 | First Light Asset Management, LLC | 13G/A | 6.5% |
Questions about Neogenomics Inc (NEO) stock
Who owns the most NEO stock?
The largest reported owner of Neogenomics Inc (NEO) is BlackRock, Inc., with 16.0% of the company. In total, 264 funds and institutions reported holding NEO at the end of Q2 2026, together about 100% of the shares. See the largest owners.
Are NEO insiders buying or selling?
In the last 12 months, NEO insiders reported no open-market purchases and 5 sales worth $968K. The latest trade was on Aug 4, 2026. See every trade.
What is the short interest in NEO?
As of Oct 30, 2026, 13.13M NEO shares were sold short, 10.2% of the shares outstanding, down 7.6% from the report before. At the average daily volume of 1.97M shares, buying them all back would take about 6.7 trading days (days to cover). See the history.
Have members of Congress traded NEO?
Yes. 1 member of Congress reported 2 purchases and 0 sales of NEO since Nov 17, 2024. The latest was reported on Sep 10, 2026. See the trades.
Which famous investors hold NEO?
3 of the 50 well-known investors we track reported NEO in their latest 13F filing, including Israel Englander, Ken Griffin, Paul Tudor Jones. The largest position is worth $42M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.